Vyne Therapeutics Inc (NASDAQ:VYNE)

0.2637
Delayed Data
As of Feb 03
 +0.0047 / +1.81%
Today’s Change
0.11
Today|||52-Week Range
0.79
+75.80%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
AssetsCash43.8M4.0M10.2M49.5M
 
 
 
 
 
Short Term Investment Cash43.5M-39.8M6.2M39.3M
 
 
 
 
 
Cash & Short Term Investments43.8M30.9M59.5M136.3M
 
 
 
 
 
 
ReceivablesReceivables0.000.00786.0K0.00
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets77.0K632.0K3.6M3.3M
 
 
 
 
 
Current Assets43.9M31.5M63.9M139.5M
 
 
 
 
 
 
Total AssetsOther Assets0.0066.0K0.00282.0K
 
 
 
Total Assets43.9M42.1M66.9M139.9M
 
 
 
 
 
 
LiabilitiesAccounts Payable637.0K1.5M2.5M3.3M
 
 
 
 
 
Accrued Expenses80.0K245.0K2.3M3.3M
 
 
 
 
 
Other Current Liabilities133.0K2.1M4.2M3.6M
 
 
 
 
 
Other Liabilities770.0K3.9M7.8M9.5M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities65.0K57.0K22.0K7.0K
 
 
 
 
 
Total Liabilities835.0K12.5M14.6M9.6M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock59.0M59.0M109.3M0.00
 
 
 
 
Common Equity-16.0M-29.4M-57.0M130.4M
 
 
 
 
 
Total Shareholder Equity43.1M29.6M52.3M130.4M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding21.4M23.0M23.0M23.2M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.